【结 构 式】 |
【分子编号】42208 【品名】(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione 【CA登记号】 |
【 分 子 式 】C27H41NO6S 【 分 子 量 】507.69168 【元素组成】C 63.88% H 8.14% N 2.76% O 18.91% S 6.32% |
合成路线1
该中间体在本合成路线中的序号:(I)The desepoxidation of epothilone B (I) by means of WCl6 and n-BuLi in THF gives the target epothilone D.
【1】 Johnson, J.A.; Kim, S.-H. (Bristol-Myers Squibb Co.); A process for the reduction of oxiranyl epothilones to olefinic epothilones. WO 0071521 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42208 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO6S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Deoxygenation of epothilone B (I) by means of tungsten hexachloride and butyllithium produced the olefin epothilone D (II). After protection of (II) as the bis-O-silylated derivative (III), cyclopropanation with chloroiodomethane and diethylzinc afforded the cyclopropane adduct (IV). A higher yield procedure to prepare (IV) involved addition of dibromocarbene, generated from bromoform and NaOH under phase-transfer conditions, to olefin (II), followed by reduction of the resulting dibromocyclopropane (V) with azobisisobutyronitrile. Finally, desilylation employing trifluoroacetic acid furnished the title compound.
【1】 Fairchild, C.; Kim, S.-H.; Gougoutas, J.; Lee, F.; Long, B.; DiMarco, J.; Vite, G.; Bifano, M.; Tokarski, J.; Johnson, J.; 288555. Drug Data Rep 2000, 22, 8, 686. |
【2】 Kim, S.-H.K.; Vite, G.D.; Hofle, G. (Bristol-Myers Squibb Co.); 12,13-Modified epothilone derivs.. WO 9954318; WO 9954319 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42208 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO6S | 详情 | 详情 | |
(II) | 40837 | (4S,7R,8S,9S,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxa-13-cyclohexadecene-2,6-dione | C27H41NO5S | 详情 | 详情 | |
(III) | 42209 | (4S,7R,8S,9S,16S)-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,8-bis[(triethylsilyl)oxy]oxa-13-cyclohexadecene-2,6-dione | C39H69NO5SSi2 | 详情 | 详情 | |
(IV) | 42210 | (1S,3S,7S,10R,11S,12S,16S)-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-7,11-bis[(triethylsilyl)oxy]-4-oxabicyclo[14.1.0]heptadecane-5,9-dione | C40H71NO5SSi2 | 详情 | 详情 | |
(V) | 42211 | (1S,3S,7S,10R,11S,12S,16R)-17,17-dibromo-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-7,11-bis[(triethylsilyl)oxy]-4-oxabicyclo[14.1.0]heptadecane-5,9-dione | C40H69Br2NO5SSi2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)The cleavage of the lactone group of epothilone B (I) by means of Na-N3 and tetrakis triphenylphosphine palladium (0) in THF gives the azido carboxylic acid (II), which is reduced with polymer-supported PPH3 (or in solution) or with H2 over PtO2 in ethanol to yield the amino acid (III). Finally, this compound is cyclized by means of diphenylphosphoryl azide (DPPA) in DMF.
【2】 Vite, G.D.; Kim, S.-H.; Johnson, J.A.; Borzilleri, R.M. (Bristol-Myers Squibb Co.); Epothilone derivs.. WO 9902514 . |
【3】 Borzilleri, R.M.; Soong-Hoon, K. (Bristol-Myers Squibb Co.); A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs. WO 9927890 . |
【1】 Borzilleri, R.M.; Zheng, X.; Schmidt, R.J.; et al.; A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products. J Am Chem Soc 2000, 122, 37, 8890. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42208 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO6S | 详情 | 详情 | |
(II) | 47825 | (3S,6R,7S,8S)-11-[(2R,3S)-3-[(2S,3E)-2-azido-3-methyl-4-(2-methyl-1,3-thiazol-4-yl)-3-butenyl]-2-methyloxiranyl]-3,7-dihydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic acid | C27H42N4O6S | 详情 | 详情 | |
(III) | 47826 | (3S,6R,7S,8S)-11-[(2R,3S)-3-[(2S,3E)-2-amino-3-methyl-4-(2-methyl-1,3-thiazol-4-yl)-3-butenyl]-2-methyloxiranyl]-3,7-dihydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic acid | C27H44N2O6S | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(I)The reaction of epothilone B (I) with MCPBA in dichloromethane gives the N-oxide (II), which is treated with trifluoroacetic anhydride and 2,6-lutidine in dichloromethane at 70 C in a sealed tube to yield the hydroxymethyl derivative (epothilone F) (III). The reaction of (III) with diphenylphosphoryl azide (DPA) and DBU in THF affords the azidomethyl compound (IV), which is reduced with PMe3 in THF or with H2 and Lindlar catalyst in ethanol to provide the target amino epothilone. Alternatively, the hydroxymethyl derivative (epothilone F) (III) can be obtained by biochemical hydroxylation of epothilone B (I) with Actinomyces sp. strain PTA-XXX.
【1】 Kim, S.-H.; Glaser, N.; Leibold, T.; Hoefle, G.; Vite, G. (Bristol-Myers Squibb Co.; Gesellschaft fur Biotechnologische Forschung mbH); C-21 modified epothilones. DE 19907588; EP 1157023; US 6262094; WO 0050423 . |
【2】 Matson, J.A.; Lam, K.S.; Huang, X.; Li, W.; McClure, G.A. (Bristol-Myers Squibb Co.); Microbial transformation method for the preparation of an epothilone. WO 0039276 . |
【3】 Lee, F.Y. (Bristol-Myers Squibb Co.); Synergistic methods and compsns. for treating cancer. WO 0172721 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42208 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO6S | 详情 | 详情 | |
(II) | 55566 | 4-{(E)-2-[(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-5,9-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-3-yl]-1-propenyl}-2-methyl-1,3-thiazol-3-ium-3-olate | C27H41NO7S | 详情 | 详情 | |
(III) | 55567 | 7,11-dihydroxy-3-{2-[2-(hydroxymethyl)-1,3-thiazol-4-yl]-1-methylethenyl}-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO7S | 详情 | 详情 | |
(IV) | 55568 | 3-{2-[2-(azidomethyl)-1,3-thiazol-4-yl]-1-methylethenyl}-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H40N4O6S | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(I)
【1】 Borzilleri RM, Zheng X, Schmidt RJ, et al. 2000. A novel applicant pf a Pd(0)-catalyzed nucleophilic substitution reaction to the regio-and stereoselective synthesis of lactam analogues of the Epothilone natural products. J Am Chem Soc, 122: 8890~8897. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42208 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | C27H41NO6S | 详情 | 详情 | |
(II) | 47825 | (3S,6R,7S,8S)-11-[(2R,3S)-3-[(2S,3E)-2-azido-3-methyl-4-(2-methyl-1,3-thiazol-4-yl)-3-butenyl]-2-methyloxiranyl]-3,7-dihydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic acid | C27H42N4O6S | 详情 | 详情 | |
(III) | 47826 | (3S,6R,7S,8S)-11-[(2R,3S)-3-[(2S,3E)-2-amino-3-methyl-4-(2-methyl-1,3-thiazol-4-yl)-3-butenyl]-2-methyloxiranyl]-3,7-dihydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic acid | C27H44N2O6S | 详情 | 详情 |